The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
MEHA · Healthcare · Narrow moat
Wonderful & reasonably priced
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
NRXS · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | TDY | MEHA | NRXS | CODA |
|---|---|---|---|---|
| Moat Score (0–100) | 64 (highest) | 64 (highest) | 64 (highest) | 64 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 90 (highest) | 66 | 57 | 48 |
| Pricing power | 65 | 90 | 100 (highest) | 98 |
| Returns on capital | 25 | — | — | 63 (highest) |
| Balance-sheet safety | 79 | 55 | 55 | 100 (highest) |
| Capital allocation | 60 (highest) | 44 | 44 | 9 |
| 161% above value if growth stopped today | 94% below value if growth stopped today (largest discount to value if growth stopped today) | No price data | 147% above value if growth stopped today | |
| Market cap | $30.3B | $86041 | $72.4M | $113M |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |